Ken Page

Active 2003–2021

Affiliations
AstraZeneca (United Kingdom)This corpus build does not record the country of an author's affiliations, so none is shown here. It does not mean these institutions have no country.
8
Papers
1,453
Citations
8
h-index
8
i10-index

Self-citations are included in these numbers.

Citations per year

Citations

Citations per year for Ken Page2003: 1 citations2004: 1 citations2005: 2 citations2006: 1 citations2010: 2 citations2011: 3 citations2012: 9 citations2013: 23 citations2014: 33 citations2015: 29 citations2016: 26 citations2017: 26 citations2018: 24 citations2019: 60 citations2020: 73 citations2021: 59 citations2022: 56 citations2023: 32 citations2024: 84 citations2025: 38 citations2026: 3 citations2007–2009: no citations, so these years are not shown

Citation sources

Countries

This corpus build does not record which country the citing authors are in, so the country breakdown is not computed. The other breakdowns below are unaffected.

Fields

  • Biochemistry, Genetics and Molecular Biology45.5%
  • Medicine27.1%
  • Pharmacology, Toxicology and Pharmaceutics10.5%
  • Computer Science7.9%
  • Chemistry5%
  • Engineering0.7%
  • Other3.3%

Topics

  • PI3K/AKT/mTOR signaling in cancer20.6%
  • Computational Drug Discovery Methods11.1%
  • DNA Repair Mechanisms9%
  • Pharmacogenetics and Drug Metabolism8.8%
  • Advanced Breast Cancer Therapies7.5%
  • Drug-Induced Hepatotoxicity and Protection6.5%
  • Other36.5%

Frequent coauthors

All papers

Loading papers…

Ken Page | Litlas